PTC Therapeutics
PTCT
207 hedge funds and large institutions have $3.52B invested in PTC Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 75 increasing their positions, 82 reducing their positions, and 32 closing their positions.
1,273% more call options, than puts
Call options by funds: $12.3M | Put options by funds: $894K
9% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 82
1.83% less ownership
Funds ownership: 107.24% → 105.41% (-1.8%)
3% less funds holding
Funds holding: 214 → 207 (-7)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
21% less capital invested
Capital invested by funds: $4.46B → $3.52B (-$946M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$63.7M |
| 2 |
AC
Armistice Capital
New York
|
+$40.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.9M |
| 4 |
N
Natixis
Paris,
France
|
+$12.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$52.5M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$13.6M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$12.2M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$11.6M |
| 5 |
Goldman Sachs
New York
|
-$11.4M |
PTCT Hedge Fund Activity: Q1 2021 in Review
207 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q1 2021, worth a combined $3.52B — down 21% from $4.46B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of PTCT and 28 opened new positions — a net loss of 4 holders — while 82 trimmed existing stakes and 75 added.
The largest buyer was RTW Investments, adding an estimated $63.7M. The largest seller was Point72 Asset Management, cutting an estimated $52.5M.
- 207 institutional investors held PTC Therapeutics (PTCT) as of Q1 2021, down from 214 in Q4 2020.
- Funds reported $3.52B of PTC Therapeutics stock for Q1 2021, down 21% quarter-over-quarter.
- 28 funds opened new PTC Therapeutics positions in Q1 2021 and 32 closed out, a net change of -4 holders.
- The largest PTC Therapeutics buyer in Q1 2021 was RTW Investments, an estimated $63.7M added.
- The largest PTC Therapeutics seller in Q1 2021 was Point72 Asset Management, an estimated $52.5M sold.
Based on aggregated 13F filings for Q1 2021.